Year: 2024

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) — Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it will effect a 1-for-15 reverse stock split at 5:00 p.m. Eastern Standard Time, on December 30, 2024. Beginning with the opening of trading on December 31, 2024, Optinose’s common stock will trade on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis under a new CUSIP number 68404V209 and Optinose’s existing trading symbol “OPTN.” The reverse stock split is intended to enable Optinose to regain compliance with the $1.00 minimum closing bid price required for continued listing on Nasdaq. At a special meeting of stockholders held on December 23, 2024, Optinose’s stockholders approved the proposal to authorize...

DALLAS, Dec. 26, 2024 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced the closing of a comprehensive refinancing of its existing indebtedness on December 24, 2024 (the “Transactions”), providing the Company with capital and liquidity to continue progressing Berry’s corporate strategy:Ensuring capital and liquidity to execute on the Company’s development plans including unlocking the significant upside potential in Utah to drive long-term shareholder value Extending the Company’s debt maturities enables Berry to execute on strategic growth opportunities that provide scale and geographic diversification Sustaining production at current levels while utilizing cash flow for capital expenditures, dividend payments and debt reduction“With our refinancing complete, Berry is well positioned...

Company recently signed a non-binding term sheet with Dr Glitter Pty Ltd for mutual development in ActivCrystal™ Format Vancouver, Canada, Dec. 26, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, recently announced that it signed a non-binding term sheet  with Dr. Glitter Pty Ltd, a health technology company that has developed ActivCrystal™ technology, a world-first oral delivery format that encapsulates active ingredients in crystals that are tasteless, odorless, made from natural ingredients, and designed to be sprinkled on meals. The two companies plan to collaborate on the development...

SHANGHAI, Dec. 26, 2024 (GLOBE NEWSWIRE) — NIO Inc. (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the global smart electric vehicle market, today announced that it is notifying holders of its 0.50% Convertible Senior Notes due 2027 (CUSIP No. 62914VAF3) (the “Notes”) that pursuant to the Indenture dated as of January 15, 2021 (the “Indenture”) relating to the Notes by and between the Company and The Deutsche Bank Trust Company Americas, as trustee, each holder has the right, at the option of such holder, to require the Company to repurchase all of such holder’s Notes or any portion thereof that is an integral multiple of US$1,000 principal amount for cash on February 1, 2025 (the “Repurchase Right”). The Repurchase Right expires at 5:00 p.m., New York City time, on Thursday, January...

GUANGZHOU, China, Dec. 26, 2024 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading Urban Air Mobility (“UAM”) technology platform company, announced a strategic partnership with the People’s Government of Fangshan District, Beijing (“Fangshan District Government”). Together, the two parties aim to advance the low-altitude emergency rescue sector by establishing EHang’s national headquarters for low-altitude emergency rescue equipment in Fangshan District, Beijing with top-level mapping of its multiple application scenarios and complete industrial chain. This initiative seeks to position the area as a hub for the low-altitude emergency rescue industry and a pilot demonstration zone for related new technologies, products and scenarios, fostering an...

Unveiling Comprehensive Automotive Display Solutions to Drive Next-Generation Smart Cabin Innovation TAINAN, Taiwan, Dec. 26, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and other semiconductors, today announced the Company will showcase the industry’s most comprehensive automotive display solutions, featuring image processing and touch IC functionalities for LCD and OLED technologies at CES 2025. During the event, Himax will highlight key advancements, including the debut of its latest, third-generation automotive TDDI solution, the HX83195 series, enabling innovative applications, and showcase the HX8530 series OLED on-cell touch IC, underscoring its comprehensive presence in the automotive display sector. With over a decade of expertise...

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – Vancouver, BC, Dec. 24, 2024 (GLOBE NEWSWIRE) — Demesne Resources Ltd. (CSE:DEME) (OTCQB:DEMRF) (“Demesne” or the “Company”) is pleased to announce that it has completed the third tranche (the “Third Tranche”) of its previously announced non-brokered private placement financing (the “Offering”). Pursuant to the Third Tranche, the Company issued 1,660,000 common shares of the Company (“Common Shares”), at a price of $0.25 per Common Share for gross proceeds of approximately $415,000.The Company plans to complete a subsequent tranche of the Offering, for gross proceeds of up to $424,599 in January 2025.In connection with the Third Tranche, the Company paid finder’s fees to eligible finders consisting of $17,150 in cash and 68,600 Common...